EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO

Today's Daily Dose brings you news about an update on Auris' phase III clinical trial of AM-111; Mallinckrodt's progress with Stannsoporfin NDA; preliminary revenue results of T2 Biosystems and Amarin, and RTI Surgical's acquisition.

from RTT - Biotech http://ift.tt/2CHE08C
via IFTTT